{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:48:02Z","timestamp":1791089282609,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.cellimm.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T19:37:04Z","timestamp":1351539424000},"page":"160-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Protective role of the vitamin D receptor"],"prefix":"10.1016","volume":"279","author":[{"given":"Lina","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2012.10.002_b0005","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ecl.2010.02.011","article-title":"The role of vitamin D in cancer prevention and treatment","volume":"39","author":"Krishnan","year":"2010","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.cellimm.2012.10.002_b0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00109-010-0590-9","article-title":"Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity","volume":"88","author":"Kamen","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.cellimm.2012.10.002_b0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1262-3636(07)70200-8","article-title":"Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence","volume":"31","author":"Reis","year":"2005","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1753-4887.2006.tb00180.x","article-title":"Vitamin D status and the metabolic syndrome","volume":"64","author":"Martini","year":"2006","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.cellimm.2012.10.002_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1463-1326.2007.00710.x","article-title":"Role of vitamin D in the pathogenesis of type 2 diabetes mellitus","volume":"10","author":"Palomer","year":"2008","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tem.2005.06.004","article-title":"Vitamin D and type 1 diabetes mellitus: state of the art","volume":"16","author":"Mathieu","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0035","first-page":"271","article-title":"The first genome-wide view of vitamin D receptor locations and their mechanistic implications","volume":"32","author":"Carlberg","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cellimm.2012.10.002_b0040","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jsbmb.2010.04.016","article-title":"Retinoic acid receptor gamma 2 interactions with vitamin D response elements","volume":"120","author":"Koszewski","year":"2010","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0045","doi-asserted-by":"crossref","first-page":"38743","DOI":"10.1074\/jbc.R110.193367","article-title":"Steroid receptor coactivator (SRC) family: masters of systems biology","volume":"285","author":"York","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-1119(00)00052-4","article-title":"Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions","volume":"246","author":"Rachez","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.cellimm.2012.10.002_b0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1753-4887.1999.tb01779.x","article-title":"Vitamin D receptor: not just in the nuclear anymore","volume":"57","author":"Fleet","year":"1999","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.cellimm.2012.10.002_b0060","doi-asserted-by":"crossref","first-page":"31859","DOI":"10.1074\/jbc.M110.116954","article-title":"Intestinal cell calcium uptake and the targeted knockout of the 1,25D3-MARRS (membrane-associated, rapid response steroid-binding) receptor\/PDIA3\/Erp57","volume":"285","author":"Nemere","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0065","doi-asserted-by":"crossref","first-page":"37041","DOI":"10.1074\/jbc.M110.157115","article-title":"Protein-disulfide isomerase-associated 3 (Pdia3) mediates the membrane response to 1,25-dihydroxyvitamin D3 in osteoblasts","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1283","article-title":"Steroid hormone rapid actions, membrane receptors and a conformational ensemble model","volume":"3","author":"Norman","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellimm.2012.10.002_b0075","series-title":"Vitamin D","first-page":"381","article-title":"1\u03b1,25(OH)2-Vitamin D3 mediated rapid and genomic responses are dependent upon critical structure-function relationships for both the ligand and receptor(s)","author":"Norman","year":"2005"},{"key":"10.1016\/j.cellimm.2012.10.002_b0080","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2012.10.002_b0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/derm.3.4.15027","article-title":"Antimicrobial implications of vitamin D","volume":"3","author":"Youssef","year":"2011","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1756283X10377820","article-title":"Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer","volume":"4","author":"Raman","year":"2011","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4161\/derm.2.1.12488","article-title":"Are Hill\u2019s criteria for causality satisfied for vitamin D and periodontal disease?","volume":"2","author":"Grant","year":"2010","journal-title":"Dermatoendocrinology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2012.10.002_b0105","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1152\/ajprenal.00471.2009","article-title":"Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats","volume":"298","author":"Park","year":"2010","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0110","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/MCB.05020-11","article-title":"1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A","volume":"31","author":"Joshi","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0115","doi-asserted-by":"crossref","first-page":"e12925","DOI":"10.1371\/journal.pone.0012925","article-title":"1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis","volume":"5","author":"Chang","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2012.10.002_b0120","first-page":"1037","article-title":"Vitamin D status and insulin requirements in children and adolescent with type 1 diabetes","volume":"24","author":"Thnc","year":"2011","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0125","first-page":"506","article-title":"Serum 25-hydroxyvitamin D (25-OH-D) in obese adolescents","volume":"62","author":"Garanty-Bogacka","year":"2011","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-009-0766-y","article-title":"Treatment of K562 cells with 1,25-dihydroxyvitamin D(3) induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCL(XL), and p21","volume":"89","author":"Kizildag","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0135","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.3748\/wjg.15.3349","article-title":"Vitamin D for the prevention and treatment of pancreatic cancer","volume":"15","author":"Chiang","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/me.2011-1109","article-title":"VDR\/RXR and TCF4\/\u03b2-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression","volume":"26","author":"Meyer","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0145","doi-asserted-by":"crossref","first-page":"565S","DOI":"10.1093\/ajcn\/88.2.565S","article-title":"Vitamin D and cancer: current dilemmas and future research needs","volume":"88","author":"Davis","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cellimm.2012.10.002_b0150","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10620-008-0375-y","article-title":"Vitamin D receptor gene polymorphisms and the risk of colorectal cancer in a Chinese population","volume":"54","author":"Li","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cellimm.2012.10.002_b0155","first-page":"803","article-title":"Gender-specific association of vitamin D receptor polymorphism combinations with type 1 diabetes mellitus","volume":"147","author":"Gy\u00f6rffy","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0160","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/eje.0.1470635","article-title":"Vitamin D receptor gene is associated with Addison\u2019s disease","volume":"147","author":"Pani","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0165","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2009.01.015","article-title":"Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations","volume":"50","author":"Tanaka","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4158\/EP11131.OR","article-title":"Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D3 in patients with Graves disease in an Egyptian population: a pilot study","volume":"18","author":"Abd El Gawad","year":"2012","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cellimm.2012.10.002_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0180","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1301\/nr.2007.aug.S102-S104","article-title":"Vitamin D receptor gene (VDR) associations with cancer","volume":"65","author":"Slattery","year":"2007","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.cellimm.2012.10.002_b0185","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2008.03413.x","article-title":"Vitamin D receptor (VDR) gene polymorphisms and Graves\u2019 disease: a meta-analysis","volume":"70","author":"Zhou","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.cellimm.2012.10.002_b0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02555137","article-title":"1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells","volume":"43","author":"Nygren","year":"1988","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0195","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/endo-125-2-935","article-title":"Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells","volume":"125","author":"Kremer","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0200","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1073\/pnas.89.17.8097","article-title":"Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitaminD3","volume":"89","author":"Demay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2012.10.002_b0205","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM198706183162504","article-title":"Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure","volume":"316","author":"Korkor","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2012.10.002_b0210","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2012.10.002_b0215","first-page":"2000","article-title":"Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism","volume":"85","author":"Carling","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0220","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.jrn.2010.01.004","article-title":"Roles of calcium-sensing receptor and vitamin d receptor in the pathophysiology of secondary hyperparathyroidism","volume":"20","author":"McCann","year":"2010","journal-title":"J. Renal Nutr."},{"key":"10.1016\/j.cellimm.2012.10.002_b0225","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1744-9987.2005.00302.x","article-title":"Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors","volume":"9","author":"Tokumoto","year":"2005","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.cellimm.2012.10.002_b0230","series-title":"Medical Physiology","author":"Boron","year":"2008"},{"key":"10.1016\/j.cellimm.2012.10.002_b0235","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.ki.5002693","article-title":"Renoprotection with vitamin D: specific for diabetic nephropathy?","volume":"73","author":"Klaus","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.ki.5002572","article-title":"Renoprotective role of the vitamin D receptor in diabetic nephropathy","volume":"73","author":"Zhang","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2012.10.002_b0250","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/sj.ki.5001624","article-title":"Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy","volume":"70","author":"Wang","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000200769","article-title":"1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-Kinase\/Aktsignaling pathway","volume":"30","author":"Xiao","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0265","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/adc.2007.128579","article-title":"Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis","volume":"93","author":"Zipitis","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cellimm.2012.10.002_b0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ecl.2010.02.013","article-title":"Vitamin D and diabetes","volume":"39","author":"Takiishi","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.cellimm.2012.10.002_b0280","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jsbmb.2010.03.042","article-title":"Vitamin D and diabetes","volume":"121","author":"Pittas","year":"2010","journal-title":"J. Sterol. Biochem. Mol. Biol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0285","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2011.08.016","article-title":"Vitamin D and diabetes: Its importance for beta cell and immune function","volume":"347","author":"Wolden-Kirk","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0290","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12291-010-0092-0","article-title":"Role of vitamin d supplementation in hypertension","volume":"26","author":"Goel","year":"2011","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0295","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.4103\/2230-8210.86979","article-title":"The thyroid hormone, parathyroid hormone and vitamin D associated hypertension","volume":"15","author":"Chopra","year":"2011","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/87.1.136","article-title":"Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the Third National Health and Nutrition Examination Survey","volume":"87","author":"Judd","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.cellimm.2012.10.002_b0305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjhyper.2007.01.017","article-title":"Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey","volume":"20","author":"Scragg","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cellimm.2012.10.002_b0310","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejcn.1602825","article-title":"Vitamin D status and health correlates among German adults","volume":"62","author":"Hintzpeter","year":"2008","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.cellimm.2012.10.002_b0315","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States\u2014data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cellimm.2012.10.002_b0320","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1152\/ajpendo.00224.2004","article-title":"Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems","volume":"288","author":"Xiang","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2012.10.002_b0325","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/en.2007-0805","article-title":"Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility","volume":"149","author":"Tishkoff","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0330","doi-asserted-by":"crossref","first-page":"H1751","DOI":"10.1152\/ajpheart.1997.272.4.H1751","article-title":"1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy","volume":"272","author":"O\u2019Connell","year":"1997","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0335","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/S0021-9258(18)61537-6","article-title":"1,25-Dihydroxyvitamin D3 stimulates 45Ca2+ uptake by cultured adult rat ventricular cardiac muscle cells","volume":"262","author":"Walters","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0340","doi-asserted-by":"crossref","first-page":"29821","DOI":"10.1074\/jbc.M705495200","article-title":"1,25-dihydroxyvitamin D3 suppresses rennin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter","volume":"282","author":"Yuan","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2012.10.002_b0345","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0350","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-291X(02)02262-3","article-title":"Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways","volume":"297","author":"Xing","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2012.10.002_b0355","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2012.10.002_b0360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.HYP.13.6.954","article-title":"1,25-DihydroxyvitaminD3 and rat vascular smooth muscle cell growth","volume":"13","author":"Carthy","year":"1989","journal-title":"Hypertension"},{"key":"10.1016\/j.cellimm.2012.10.002_b0365","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1471-4914(02)02294-3","article-title":"The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents","volume":"8","author":"Mathieu","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cellimm.2012.10.002_b0370","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2005.06.046","article-title":"Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells","volume":"186","author":"Wu-Wong","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cellimm.2012.10.002_b0375","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jcb.21133","article-title":"VDR mediated gene expression patterns in resting human coronary artery smooth muscle cells","volume":"100","author":"Wu-Wong","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.cellimm.2012.10.002_b0380","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2005.00651.x","article-title":"Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?","volume":"68","author":"Levin","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0385","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2009080872","article-title":"Vitamin D receptor attenuates renal fibrosis by suppressing the renin-angiotensin system","volume":"21","author":"Zhang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0390","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/ki.2008.408","article-title":"Suppression of renin-angiotensin gene expression in the kidney by paricalcitol","volume":"74","author":"Freundlich","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0395","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157339908783502370","article-title":"Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy","volume":"4","author":"Ziyadeh","year":"2008","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.cellimm.2012.10.002_b0400","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0303-7207(85)90074-7","article-title":"Interaction of 1,25 dihydroxyvitamin D3 and the immune system","volume":"43","author":"Manolagas","year":"1985","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0405","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.1989.tb04250.x","article-title":"Annotation vitamin D and human leukemia","volume":"71","author":"Kelsey","year":"1989","journal-title":"Br. J. Helmatol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0410","first-page":"423","article-title":"Effect of 1,25-dihydroxyvitaminD3 on mesangial cell proliferation","volume":"117","author":"Hariharan","year":"1991","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cellimm.2012.10.002_b0415","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0272-6386(12)80096-5","article-title":"Actions of 1,25dihydroxyvitamin D3 on human mesangial cells","volume":"18","author":"Weinreich","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellimm.2012.10.002_b0420","first-page":"1390","article-title":"Inhibition of growth by calcitriol in a proximal tubular cell line","volume":"9","author":"Weih","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cellimm.2012.10.002_b0425","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.1993.tb08210.x","article-title":"Partial prevention of active Heymann nephritis by 1alpha,25-dihydroxy vitamin D3","volume":"94","author":"Branisteanu","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0430","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25(OH)2 vitaminD3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0435","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1alpha 25-DihydroxyvitaminD3 inhibits differentiation, maturation, activation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"PennaG","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0440","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0445","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.cellimm.2012.10.002_b0450","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2012.10.002_b0455","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0460","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)64129-6","article-title":"A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis","volume":"158","author":"Makibayashi","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0465","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jsbmb.2006.11.011","article-title":"Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis","volume":"103","author":"Tan","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0470","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0475","doi-asserted-by":"crossref","first-page":"15896","DOI":"10.1073\/pnas.0803751105","article-title":"Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2012.10.002_b0480","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00007890-199810150-00002","article-title":"Prolongation of allograft survival by 1,25-dihydroxyvitamin D3","volume":"66","author":"Hullett","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cellimm.2012.10.002_b0485","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1523-1755.2002.00101.x","article-title":"1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants","volume":"61","author":"Redaelli","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0490","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/jhep.2001.28705","article-title":"1alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts","volume":"34","author":"Redaelli","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2012.10.002_b0495","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.4049\/jimmunol.167.4.1945","article-title":"Regulatory T cells induced by 1alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance","volume":"167","author":"Gregori","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0500","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.2000.2490","article-title":"Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs","volume":"270","author":"Griffin","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellimm.2012.10.002_b0505","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.1073\/pnas.121172198","article-title":"Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo","volume":"98","author":"Griffin","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2012.10.002_b0510","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","article-title":"1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the posttranscriptional level","volume":"4","author":"Muller","year":"1992","journal-title":"Cytokine"},{"key":"10.1016\/j.cellimm.2012.10.002_b0515","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11255-009-9541-1","article-title":"Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells","volume":"42","author":"Eleftheriadis","year":"2010","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0520","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cellimm.2012.10.002_b0525","first-page":"129","article-title":"Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients","volume":"6","author":"Eleftheriadis","year":"2012","journal-title":"Iran J. Kidney. Dis."},{"key":"10.1016\/j.cellimm.2012.10.002_b0530","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1681\/ASN.2007060666","article-title":"Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling","volume":"l19","author":"Tan","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0535","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ki.2010.69","article-title":"Paricalcitol attenuates cyclosporine-induced kidney injury in rats","volume":"77","author":"Park","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0540","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cellimm.2011.06.017","article-title":"Effect of 1,25(OH)2D3 on rat peritoneal mesothelial cells treated with high glucose plus lipopolysaccharide[J]","volume":"271","author":"Yang","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0545","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.ki.5002296","article-title":"1,25-Dihydroxyvitamin D(3) targeting of NF kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells","volume":"72","author":"Zhang","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0550","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0555","doi-asserted-by":"crossref","first-page":"F1212","DOI":"10.1152\/ajprenal.00002.2009","article-title":"1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-kappaB pathway","volume":"296","author":"Deb","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0560","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellimm.2012.10.002_b0565","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1681\/ASN.2006050520","article-title":"Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy","volume":"17","author":"Tan","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0570","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/JOE-08-0241","article-title":"Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells","volume":"200","author":"Artaza","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0575","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2008060566","article-title":"Wnt\/beta-catenin signaling promotes renal interstitial fibrosis","volume":"20","author":"He","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellimm.2012.10.002_b0580","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1038\/onc.2009.285","article-title":"SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue","volume":"28","author":"Pe\u00f1a","year":"2009","journal-title":"Oncogene"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874912001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874912001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:49:29Z","timestamp":1757803769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874912001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0008874912001864"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2012.10.002","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective role of the vitamin D receptor","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2012.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2012 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}